McKesson (MCK)
(Delayed Data from NYSE)
$585.74 USD
+2.74 (0.47%)
Updated Jul 23, 2024 04:00 PM ET
After-Market: $585.51 -0.23 (-0.04%) 7:58 PM ET
3-Hold of 5 3
A Value A Growth A Momentum A VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
MCK 585.74 +2.74(0.47%)
Will MCK be a Portfolio Killer in July?
Zacks Investment Research is releasing its prediction for MCK based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for MCK
McKesson (MCK) Increases Despite Market Slip: Here's What You Need to Know
These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar
MCK: What are Zacks experts saying now?
Zacks Private Portfolio Services
Want Better Returns? Don?t Ignore These 2 Medical Stocks Set to Beat Earnings
CGM Sensor Demand Likely to Drive DexCom (DXCM) Q2 Earnings
Intuitive Surgical (ISRG) Hits All-Time High: Will It Go Higher?
Other News for MCK
Healthcare 2024 Second Half Outlook
McKesson (MCK) Receives a Buy from Barclays
McKesson price target raised by $50 at Citi, here's why
Looking Into McKesson's Recent Short Interest
September 20th Options Now Available For McKesson (MCK)